OliX Pharmaceuticals Subsidiary mCureX Announces mRNA Technology Collaboration with ToolGen for Rare Eye Disease
SUWON, South Korea--(BUSINESS WIRE)-- #AgeRelatedMacularDegeneration--OliX Pharmaceuticals' subsidiary mCureX Therapeutics announced an mRNA technology collaboration with ToolGen for rare eye diseases.